# GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease

> **NCT02377336** · PHASE2 · WITHDRAWN · sponsor: **Gilead Sciences**

## Conditions studied

- Ischemic Heart Disease

## Interventions

- **DRUG:** GS-6615
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02377336
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2015-05
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Anticipated recruitment challenges
- **Last updated:** 2015-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02377336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02377336, "GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT02377336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
